Pages that link to "Q48045473"

The following pages link to Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas (Q48045473):

Displaying 50 items.

• The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region (Q22010498) (← links)
• The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation (Q24678674) (← links)
• Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility (Q24679438) (← links)
• PTEN deficiency: a role in mammary carcinogenesis (Q24801835) (← links)
• New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists (Q24806542) (← links)
• Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis (Q28117749) (← links)
• Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers (Q28393163) (← links)
• Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems (Q28586004) (← links)
• Germline PTEN mutations in Cowden syndrome-like families. (Q33681468) (← links)
• DNA copy number losses in human neoplasms (Q33733232) (← links)
• PI(3,4)P2 plays critical roles in the regulation of focal adhesion dynamics of MDA-MB-231 breast cancer cells (Q33738762) (← links)
• Concurrent BRAF and PTEN mutations in melanoma of unknown origin presenting as a breast mass (Q33757319) (← links)
• The genetics of inherited breast cancer (Q33923794) (← links)
• Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer (Q34043823) (← links)
• Protocol for PTEN expression by immunohistochemistry in formalin-fixed paraffin-embedded human breast carcinoma (Q34066409) (← links)
• PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation (Q34514602) (← links)
• The contribution of inherited factors to the clinicopathological features and behavior of breast cancer (Q34639877) (← links)
• Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging (Q34966603) (← links)
• Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field (Q34996130) (← links)
• Mechanistic Analysis of a DNA Damage-Induced, PTEN-Dependent Size Checkpoint in Human Cells (Q35096583) (← links)
• Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis (Q35250337) (← links)
• Analysis of genetic and phenotypic heterogeneity in juvenile polyposis (Q35359948) (← links)
• Identification of PTEN mutations in metastatic melanoma specimens (Q35435625) (← links)
• Elevated PI3K signaling drives multiple Breast Cancer subtypes (Q35640263) (← links)
• Epigenetic PTEN silencing in malignant melanomas without PTEN mutation (Q35745799) (← links)
• DNA copy number changes in development and progression in leiomyosarcomas of soft tissues (Q35753414) (← links)
• Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast (Q35788322) (← links)
• Treatment of HER2-positive metastatic breast cancer following initial progression (Q36275971) (← links)
• Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors (Q36278252) (← links)
• The mTOR pathway in breast cancer (Q36561728) (← links)
• Somatic mutation of PTEN in bladder carcinoma (Q36617723) (← links)
• Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. (Q36618853) (← links)
• Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas (Q36618879) (← links)
• Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas. (Q36619048) (← links)
• Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus (Q36622406) (← links)
• Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas (Q36645975) (← links)
• Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response (Q36862768) (← links)
• Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy (Q36973814) (← links)
• PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling (Q37116576) (← links)
• The association of PTEN hypermethylation and breast cancer: a meta-analysis (Q37261822) (← links)
• Targeting the PI3-kinase/Akt/mTOR signaling pathway (Q37265126) (← links)
• The molecular genetics of breast cancer and targeted therapy (Q37290512) (← links)
• The rapamycin-regulated gene expression signature determines prognosis for breast cancer (Q37386133) (← links)
• WWP2 is an E3 ubiquitin ligase for PTEN (Q37588182) (← links)
• Phenotype-genotype correlation in familial breast cancer (Q37852615) (← links)
• PTEN protein expression in malignant pleural mesothelioma (Q38398970) (← links)
• MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells. (Q39064248) (← links)
• BAG5 regulates PTEN stability in MCF-7 cell line (Q39073672) (← links)
• Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN (Q39711051) (← links)
• Effect of PTEN Gene Mutations and Environmental Risk Factors on the Progression and Prognosis of Bladder Cancer. (Q40850887) (← links)